Great Point Partners LLC Ventyx Biosciences, Inc. Transaction History

Great Point Partners LLC

  • $216 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$24.16 - $36.38 $3.16 Million - $4.76 Million
130,728 Added 48.42%
400,695 $13.1 Million
Q3 2022

Nov 14, 2022
SELL
$12.64 - $38.7 $1.51 Million - $4.62 Million
-119,256 Reduced 30.64%
269,967 $9.43 Million
Q2 2022

Aug 15, 2022
BUY
$11.95 - $18.75 $632,023 - $991,668
52,889 Added 15.73%
389,223 $4.76 Million
Q1 2022

May 16, 2022
BUY
$10.0 - $19.98 $3.36 Million - $6.72 Million
336,334 New
336,334 $4.56 Million

Others Institutions Holding VTYX

# of Institutions
125
Shares Held
52.9M
Call Options Held
35.3K
Put Options Held
83K
View Full List

About Ventyx Biosciences, Inc.

VTYX Quotes by TradingView
  • Ticker VTYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,527,200
  • Market Cap $132M
  • Description
  • Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...
More about VTYX
Track This Portfolio

Track Great Point Partners LLC Portfolio

Follow Great Point Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Point Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Point Partners LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email